Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1191.3000 35.20 (3.04%)
NSE Jul 04, 2025 15:31 PM
Volume: 1.9M
 

logo
Aurobindo Pharma Ltd.
06 Jun 2016
1191.30
3.04%
Economic Times
The company paid its CEO, M Govindarajan, an average annual compensation of Rs 9.5 crore, which is above the average CEO salary during the period.
Promoters unpledged 0.91% of shares in last quarter. Total pledge stands at 16.92% of promoter holdings
Aurobindo Pharma gets best value from payout to CEO in 3 years
Economic Times | 06 Jun 2016
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - July 04, 2025
The Baseline | 04 Jul 2025, 05:12PM
Market closes higher, Bajaj Finance's AUM grows 25% YoY crore in Q1FY26
Trendlyne Marketwatch | 04 Jul 2025, 04:01PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020